SK1-IN-1 is a potent sphingosine kinase 1 (SPHK1) inhibitor with an IC50 of 58 nM; it demonstrates significant improvement in intrinsic clearance, particularly against human liver microsomes, and shows modest oral bioavailability with acceptable half-lives in blood circulation, making it suitable for rat pharmacokinetic (PK) studies.